Skip to main content

Time in Range News

Time in Range (TIR) is the percentage of time that a person spends with their blood glucose levels in the target range, usually between 70 and 180 mg/dl.

diaTribe and the Time in Range Coalition, in a global effort to raise the awareness and adoption of Time in Range and the use of continuous glucose monitors (CGM),...
Telehealth visits skyrocketed during the pandemic, as did the demand for at-home A1C tests. They are convenient and quick, but how accurate are they? And should they be...
A study recently published in the New England Journal of Medicine shows that a bionic pancreas, or a closed-loop automated insulin delivery system, kept blood glucose...
Managing your Time in Range (TIR) can be challenging, but there are several apps you can download to help you. In this article, we cover 14 apps you may want to check...
Continuous glucose monitors (CGM) are a valuable tool, allowing people with diabetes to stay informed to make decisions without having to constantly prick their fingers...
Healthcare providers and people with diabetes are finding that time in range (TIR) provides clear and timely information for managing your blood glucose. diaTribe Senior...
Unfortunately, healthcare professionals can sometimes contribute to diabetes stigma. However, discussing Time in Range may help empower people with diabetes and reduce...
Time in range (TIR) is an actionable metric that captures the highs, lows and in-range glucose values that people with diabetes experience each day. Because TIR shows...
A team of world-renowned experts in diabetes presented updates about automated insulin delivery (AID), focusing on the role of diet and exercise for closed-loop systems.
In April 2022, 32 of the world’s premier diabetes experts gathered in Barcelona, along with representatives from industry, advocacy, and regulatory bodies, to discuss...
​For the first time, Time in Range was used as the main outcome measured in a clinical trial for a diabetes medication. Read about the study results and implications.
Find out more from experts about the latest advancements in continuous glucose monitoring, ketone monitors, and non-invasive technologies.
The diaTribe team was on-the-ground in Barcelona, Spain to cover the latest news in diabetes technology from the ATTD 2022 international conference. Here are our top...
At this year’s Advanced Technologies and Treatment conference in Barcelona, diaTribe will bring together dozens of experts in diabetes for a revolutionary consensus...
The diaTribe team is excited to cover all the latest news in diabetes technology and treatments, attending our first in-person diabetes conference in over two years!...
In October 2022, Dexcom announced that its next-generation continuous glucose monitor (CGM), Dexcom G7, is now available to people with diabetes in Hong Kong and several...
Time in Range (TIR) is an effective tool to use in your daily diabetes management, but how can you actually spend more of your day in range? Read below for some helpful...
Time in Range (TIR) is more than just another diabetes metric; it is a tool that can be used to improve communication with your healthcare providers and empower you both...
Each year, the American Diabetes Association updates its Standards of Care, or recommended diabetes practice guidelines. The document includes recommendations for target...
The Eversense E3 continuous glucose monitor (CGM) has been approved by the FDA and it has received a CE Mark approval in Europe for people with diabetes aged 18 and...

Pages